Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
2021 · Journal for ImmunoTherapy of Cancer · 234 citations
https://doi.org/10.1136/jitc-2020-001895
R
Ruiqi Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
176
Papers
2.5K
Citations
24
h-index
46
i10-index
Ruiqi Liu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Immunotherapy and Biomarkers & Bladder and Urothelial Cancer Treatments. The author has an h-index of 24, co-authored 150 publications.
ORCID: 0000-0002-2099-620XPapers by this author
worksHedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state
2022 · Developmental Cell · 74 citations
https://doi.org/10.1016/j.devcel.2022.06.005
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
2025 · Cell Communication and Signaling · 54 citations
https://doi.org/10.1186/s12964-024-02018-6
Association of <i>KMT2C/D</i> loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
2023 · Cancer Science · 26 citations
https://doi.org/10.1111/cas.15716
The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis
2023 · Asia-Pacific Journal of Oncology Nursing · 26 citations
https://doi.org/10.1016/j.apjon.2023.100200
Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass
2016 · Journal of Cardiothoracic Surgery · 22 citations
https://doi.org/10.1186/s13019-016-0481-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat